Sign In
TEVA.US
id: 268
D. Connecticut
Court
06 Feb 2014
Class period Start
10 May 2019
Class period End
17 May 2022
Claim deadline
IN RE TEVA SECURITIES LITIGATION
"The Action alleges that Defendants made material misstatements and omissions regarding the sources of Teva’s financial performance, generic drug pricing, collusion, and other matters. Defendants deny any wrongdoing or liability. The parties disagree on liability and damages. Class Representatives wish to avoid the risk and delay of further litigation and secure a substantial benefit for the Settlement Class. Defendants wish to avoid the cost and distraction of further litigation."
Case Status
Disbursed
Alleged Offence
Other
Suspected Party
Other
Security Type
Depository Securities (ADS, ADR, GDR)
Trade Direction
Long
Plaintiffs
Ontario Teachers’ Pension Plan Board,Anchorage Police & Fire Retirement System
Attorneys
Bleichmar Fonti & Auld LLP
Judge
Hon. Stefan R. Underhill
Administrator
EPIQ
Court hearing date
02 June 2022
Trades matching type
FIFO
+$420,000,000
Cash Settlement Amount

Teva Pharma Industries Ltd ADR

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and ...

    Ticker
    TEVA.US
    ISIN
    US8816242098
    CIK
    818686
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Country
    USA
    Address
    124 Dvora HaNevi?a Street, Tel Aviv, Israel, 6944020